To include your compound in the COVID-19 Resource Center, submit it here.

Skin grafts based on CRISPR-edited iPS cells to treat epidermolysis bullosa

DISEASE CATEGORY: Dermatology

INDICATION: Blistering disorder

Skin grafts based on CRISPR-edited induced pluripotent stem (iPS) cells could treat recessive

Read the full 173 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE